OAB-062: Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to BCMA-targeting bispecific antibody treatment
Titel:
OAB-062: Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to BCMA-targeting bispecific antibody treatment
Auteur:
San-Miguel, Jesus Mateos, MarĂa-Victoria Cohen, Yael C. Rodriguez-Otero, Paula Paiva, Bruno van de Donk, Niels W.C.J. Martin, Thomas Abu-Zaid, Mohammad Corsale, Christina Schecter, Jordan M. De Braganca, Kevin C. Varsos, Helen Deraedt, William Wang, Liwei Roccia, Tito Li, Claire Mistry, Pankaj Xu, Xiaoying Zudaire, Enrique Akram, Muhammad Nesheiwat, Tonia Pacaud, Lida Avivi, Irit Cohen, Adam D.